Deutsche Bank’s HTG Molecular Diagnostics HTGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-99
Closed -$11K – 5197
2019
Q3
$11K Buy
+99
New +$19.9K ﹤0.01% 4486
2019
Q1
– Sell
-12
Closed -$11K – 5626
2018
Q3
$11K Sell
12
-40
-77% -$26.4K ﹤0.01% 5066
2018
Q2
$31K Buy
52
+51
+5,100% +$33.3K ﹤0.01% 4909
2018
Q1
$0 Hold
1
– – ﹤0.01% 5423
2017
Q4
$4K Buy
12
+5
+71% +$1.91K ﹤0.01% 4882
2017
Q3
$2K Buy
7
+4
+133% +$1.52K ﹤0.01% 4804
2017
Q2
$1K Buy
3
+2
+200% +$1.52K ﹤0.01% 4884
2017
Q1
$0 Hold
1
– – ﹤0.01% 5175
2016
Q4
$0 Sell
1
-140
-99% -$55.8K ﹤0.01% 5138
2016
Q3
$57K Buy
141
+16
+13% +$7.15K ﹤0.01% 4166
2016
Q2
$61K Buy
125
+100
+400% +$50.8K ﹤0.01% 4326
2016
Q1
$12K Buy
+25
New +$14K ﹤0.01% 4787

Other funds holding HTGM

Deutsche Bank's HTGM Position: Q4 2019 in Review

Deutsche Bank sold out of HTG Molecular Diagnostics (HTGM) in Q4 2019, closing a stake of 99 shares — an estimated $11K sold.

Deutsche Bank first reported a position in HTGM in Q1 2016 and held it in 12 quarters. The position peaked at $61K in Q2 2016. 27 funds tracked by Wall St. Rank hold HTGM as of Q4 2019.

  • Deutsche Bank reported no remaining HTG Molecular Diagnostics position as of Q4 2019 after selling out during the quarter.
  • Deutsche Bank sold 99 HTG Molecular Diagnostics shares in Q4 2019, an estimated $11K.
  • Deutsche Bank first reported a position in HTG Molecular Diagnostics in Q1 2016 and held it in 12 quarters.
  • Deutsche Bank's HTG Molecular Diagnostics position peaked at $61K in Q2 2016.
  • 27 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q4 2019.

Based on Deutsche Bank's 13F filing for Q4 2019, filed 14 Feb 2020.